INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 79 filers reported holding INSTIL BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,334 | -22.3% | 63,864 | 0.0% | 0.00% | – |
Q2 2023 | $35,189 | +83683.3% | 63,864 | 0.0% | 0.00% | -100.0% |
Q1 2023 | $42 | +5.0% | 63,864 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $40 | -99.9% | 63,864 | +364.5% | 0.00% | 0.0% |
Q3 2022 | $67,000 | -77.4% | 13,749 | -78.6% | 0.00% | -87.5% |
Q2 2022 | $297,000 | -25.0% | 64,350 | +74.6% | 0.01% | -11.1% |
Q1 2022 | $396,000 | – | 36,863 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Curative Ventures V LLC | 37,980,073 | $183,824,000 | 100.00% |
CPMG Inc | 8,218,467 | $39,777,000 | 7.80% |
Vivo Capital, LLC | 12,486,787 | $60,436,000 | 6.67% |
VR Adviser, LLC | 4,105,779 | $19,872,000 | 3.07% |
Samsara BioCapital, LLC | 1,788,280 | $8,655,000 | 2.02% |
Parametrica Management Ltd | 88,263 | $428,000 | 0.88% |
RA Capital Management | 7,670,793 | $37,127,000 | 0.79% |
Fairmount Funds Management LLC | 673,905 | $3,262,000 | 0.57% |
Nicholas Investment Partners, LP | 897,386 | $4,343,000 | 0.40% |
Logos Global Management LP | 331,872 | $1,606,000 | 0.20% |